Abstract
Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Adolescent Psychiatry
Title: Albert Ellis Rational-Emotive Behavior Therapy
Volume: 1 Issue: 1
Author(s): Richard Rosner
Affiliation:
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Abstract: Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Export Options
About this article
Cite this article as:
Rosner Richard, Albert Ellis Rational-Emotive Behavior Therapy, Adolescent Psychiatry 2011; 1 (1) . https://dx.doi.org/10.2174/2210676611101010082
DOI https://dx.doi.org/10.2174/2210676611101010082 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD
Current Alzheimer Research Nummular Eczema: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Turning REST/NRSF Dysfunction in Huntingtons Disease into a Pharmaceutical Target
Current Pharmaceutical Design MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising
Current Pharmaceutical Design CIITA and the MHCII Enhanceosome in the Regulation of MHCII Expression
Current Genomics Targeting DNA Topoisomerase I with Non-Camptothecin Poisons
Current Medicinal Chemistry Intestinal Fibrosis in Crohns Disease: Medical Treatment or Surgery?
Current Drug Targets Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology Viral Encephalitis: Current Treatments and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry Control of Menopausal Transition through Physical Exercises
Current Women`s Health Reviews Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies
Current Pharmaceutical Design Herbal Medicine as an Alternative Treatment in Autism Spectrum Disorder: A Systematic Review
Current Drug Metabolism The Central Role of Leukotriene B4 in Epstein Barr Virus Activated Innate Immunity In Vitro
Current Immunology Reviews (Discontinued) Unmasking Sex-Based Disparity in Neuronal Metabolism
Current Pharmaceutical Design Traumatic Stress Reactions in Parents in Pediatric Intensive Care: A Review
Current Psychiatry Reviews Dogs with Cognitive Dysfunction Syndrome: A Natural Model of Alzheimer’s Disease
Current Alzheimer Research Does Calprotectin Represent a Regulatory Factor in Host Defense or a Drug Target in Inflammatory Disease?
Endocrine, Metabolic & Immune Disorders - Drug Targets Is Glyburide Safe in Pregnancy?
Current Pharmaceutical Biotechnology Drugs of Abuse-Induced Hyperthermia, Blood-Brain Barrier Dysfunction and Neurotoxicity: Neuroprotective Effects of a New Antioxidant Compound H-290/51
Current Pharmaceutical Design Chemoprevention of Lung Pathologies by Dietary n-3 Polyunsaturated Fatty Acids
Current Medicinal Chemistry